CellPro Japan Corporation
Basic information
- Head office
- Kanagawa Prefecture, Fujisawa City, Muraoka Higashi 2-chome, 26-1
- Chief executive
- Fumihira Samata
- Capital
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
|
|
Network
History
News
Medicacell HA Stem Serum Sells Out Again on QVC
Medicacell HA Stem Serum sold out again after strong demand on shopping channel QVC. Although inventory was about twice the previous amount, orders surged during the early-morning broadcast and all stock sold out while it was on air. The president and CEO commented that the product is attracting attention in regenerative beauty.
Patent Granted for Cell Culture and Culture Supernatant Production Methods
Cellpro Japan Inc. obtained a domestic patent for a new method of producing human stem cell-derived culture supernatant. The method raises glucose levels in the basal medium to improve cell proliferation and the concentration of beneficial components, addressing low cell viability and growth with conventional media. A PCT international application was filed in October 2023, and overseas expansion is under consideration.
Medicacell HA Stem Serum Sells Out Shortly After QVC Launch
Cellpro Japan Inc. launched Medicacell HA Stem Serum on QVC on May 14, 2025, and it sold out about 11 minutes after the broadcast began. The serum contains 50% human amniotic membrane-derived stem cell conditioned culture medium and is primarily marketed to beauty clinics and salons. The company is considering another QVC sale, new sales channels, and development of related products.
Cellpro Japan to Expand Blood Processing Center
Cellpro Japan will expand its blood processing center in Ota-ku, Tokyo, to meet growing demand for contract blood-derived processing services. Since the service launched in 2022, the number of partner medical institutions and contract cases has grown, and the company plans to introduce new technologies.
Bunpei Samata to Speak at the 113th Annual Meeting of the Japan Society of Aesthetic Surgery
Cellpro Japan Inc. President and CEO Bunpei Samata will take part in a panel discussion at the Japan Society of Aesthetic Surgery meeting on May 29, 2025. The panel will discuss collaboration between regenerative and aesthetic medicine, the current landscape, and future challenges.
Cellpro Japan Announces Patent Application for New Technology
Cellpro Japan has completed a patent application for new technology related to its PDF-FD blood processing service. The technology raises growth factor concentrations to about 20 times the conventional level while maintaining safety, increasing the concentration of blood components. It aims to address treatment needs such as knee joint conditions in older adults.
Cellpro Japan President Elected as Councilor of the Japanese Society for Regenerative Medicine
Fumihira Samata, president and representative director of Cellpro Japan Co., Ltd., was elected as a councilor of the Japanese Society for Regenerative Medicine, a general incorporated association. The society promotes progress in regenerative medicine through research and policy recommendations. Mr. Samata plans to deepen understanding of regenerative medicine’s role in society and contribute to research and its application for public benefit.
Public records
National Tax Agency basic information5021001067195
- Trade name
- セルプロジャパン株式会社
- Trade name (kana)
- セルプロジャパン
- Name in English
- Corporation type
- 301
- Address
- 〒251-0012 神奈川県藤沢市村岡東2丁目26番地の1
- Postal code
- 2510012
- Prefecture code
- 14
- City code
- 205
- Address outside Japan
- Prefecture in English
- City in English
- Address outside Japan in English
- Corporate number assignment date
- 2019-05-13
- Update date
- 2019-05-16
- Change date
- 2019-05-13
- Registry closure date
- Reason for registry closure
- Successor corporate number
- Details of the change
- Latest record
- 1
- Excluded from search
- 0
- Processing type
- 01
- Correction type
- 0
- Trade name image ID
- Address image ID
- Sequence number
- 2803631
METI gBizINFO5021001067195
- Corporate number
- 5021001067195
- Trade name
- セルプロジャパン株式会社
- Trade name (kana)
- セルプロジャパン
- Trade name (alphabet)
- Registry closure date
- Reason for registry closure
- Registered address
- 神奈川県藤沢市村岡東2丁目26番地の1
- Postal code
- 2510012
- Prefecture
- 神奈川県
- Prefecture code
- 14
- City or district
- 藤沢市
- City code
- 205
- Street address
- 村岡東2丁目26番地の1
- Organisation type
- 301
- Processing type
- 01
- Correction type
- 0
- Status
- Representative
- Capital
- Employees
- 29
- Employees (male)
- 12
- Employees (female)
- 17
- Business summary
- Website URL
- Year founded
- Business category
- E:製造業
- Date established
- Unified government qualification - grade
- Unified government qualification - business items
- Update date
- 2019-05-16
- Key information
- 5021001067195